Abstract
Inflammation that is an independent predictor of cardiovascular disease plays a important role in rheumatological diseases. Asymmetric dimethylarginine (ADMA), an inhibitor of endogenous nitric oxide synthase, contributes to the inflammatory syndrome. Elevated ADMA levels in many rheumatological diseases suggest that ADMA might play an important role in the rheumatological diseases and cardiovascular complication. In this review, we discuss the role of ADMA in rheumatological disease's cardiovascular complications. Key words: Arginine/ME; Rheumatic diseases/CO/ME; Immune system diseases/CO/ME; Review
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
